B01AC30 · Blood and blood-forming organs
Clopidogrel/Acetylsalicylic acid Teva
Indications
Clopidogrel/Acetylsalicylic acid Teva is indicated for the prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (ASA). Clopidogrel/Acetylsalicylic acid Teva is a fixed?dose combination medicinal product for continuation of therapy in: Non?ST segment elevation acute coronary syndrome (unstable angina or non?Q?wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention ST segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy
Composition
- Active substance
- clopidogrel, acetylsalicylic acid
- International name (INN)
- clopidogrel;acetylsalicylic acid
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Clopidogrel/Acetylsalicylic acid Teva
- Active substance
- clopidogrel, acetylsalicylic acid